CD63 and CD9 tetraspanins promote tumor development and determine invasiveness in certain cancer types [50,51,52], while glycosylation, as a post-translational process, has a key role in modulating the expression and molecular function of these membrane proteins [51]. The gene discussed is CD9; the disease is cancer.